Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11-Reference-Cited by-同舟云学术

Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11

Published:2008-03 Issue:3 Volume:49 Page:612-624
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Dhar Madhurima,Sepkovic Daniel W.,Hirani Vandana,Magnusson Ronald P.,Lasker Jerome M.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference42 articles.

1. Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders;Costa;Clin. Chem.,1998

2. Molecular basis for the omega-regiospecificity of the CYP4A2 and CYP4A3 fatty acid hydroxylases;Hoch;J. Biol. Chem.,2000

3. Catalytic activity and isoform-specific inhibition of rat cytochrome P450 4F enzymes;Xu;J. Pharmacol. Exp. Ther.,2004

4. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11;Powell;J. Pharmacol. Exp. Ther.,1998

5. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes;Powell;Arch. Biochem. Biophys.,1996

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review;Biochemical Pharmacology;2024-05

2. Deciphering the Role of Fatty Acid–Metabolizing CYP4F11 in Lung Cancer and Its Potential As a Drug Target;Drug Metabolism and Disposition;2023-11-16

3. Expected and Unexpected Products from the Biochemical Oxidation of Bacterial Alkylquinolones with CYP4F11;Journal of Natural Products;2023-11-08

4. Deciphering the biotransformation mechanism of dialkylresorcinols by CYP4F11;Bioorganic Chemistry;2023-02

5. Ligand appended theranostic nanocarriers for targeted blood–brain barrier;Design and Applications of Theranostic Nanomedicines;2023